Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 4:50 PM ET


Company Overview of Knight Therapeutics Inc.

Executive Profile

Jonathan Ross Goodman BA, LLB, MBA

Chief Executive Officer, President and Director, Knight Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 10 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Jonathan Ross Goodman, BA, LLB, MBA serves as the Chief Executive Officer and President at Knight Therapeutics Inc. Mr. Goodman co-founded Paladin Labs Inc. in 1995, and served as its President and Chief Executive Officer from 1995 to May 29, 2012. Mr. Goodman was a Consultant with Bain & Company and worked in brand management for Procter & Gamble. Mr. Goodman served as Vice President of Business Development at Pharmascience Inc, where he led Pharmascience-s successful ...

Corporate Headquarters

376 Victoria Avenue
Westmount, Quebec H3Z 1C3


Phone: 514-484-4483
Fax: 514-481-4116

Board Members Memberships

Co-Founder and Chairman
Director, Chairman of Human Resources & Corporate Governance Committee and Member of Audit Committee
Chief Executive Officer, President and Director


LLB 1994
McGill University
McGill University
MBA 1994
McGill University
The London School of Economics and Political Science

Other Affiliations

Annual Compensation

Total Annual CompensationC$1

Stocks Options

Total Value of OptionsC$1,506,817
Total Number of OptionsC$1,186,470

Total Compensation

Total Annual Cash CompensationC$450,001
Total Short Term CompensationC$1
Total Calculated CompensationC$4,329,758

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Knight Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at